FDA Drugs recall ·
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10)… recall
Read the official FDA notice ↗
Product
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Why was it recalled?
Labeling: Label Mix-up
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # 1030023, Exp Date: 06/30/2027.
Distribution
US Nationwide.
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0840-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.